Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 13, Issue 18 pp 22459—22473
miR-19b-3p relieves intervertebral disc degeneration through modulating PTEN/PI3K/Akt/mTOR signaling pathway
Figure 6. Inhibiting PTEN enhanced the protective effect of miR-19b-3p. In the in-vitro IL-1β-induced IVDD model, HNPCs were transfected with miR-19b-3p mimics or treated with the mTOR inhibitor (50 nM) for 24 hours. (A) The miR-19b-3p level was gauged by qRT-PCR. (B) The expression of MMP-3, MMP-9, MMP-13, ADAMTS-4 and ADAMTS-5 were tested by WB. (C, D) CCK-8 and TUNEL staining were adopted to examine cell proliferation and apoptosis of each group. (E) WB was used to test the PTEN/PI3K/Akt/mTOR pathway expression. * P <0.05, ** P <0.01, *** P <0.001 (vs.IL-1β group). & P <0.05, && P <0.01 (vs.IL-1β+miR-19b-3p group). N=3.